Žemaitijos diagnostikos centras, UAB - financials and debts
Company age: 17 y. 9 mo.
Žemaitijos diagnostikos centras - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 722,833 | 823,545 | 667,058 | 707,501 | 949,576 | 1,345,729 | 1,851,380 | 2,105,068 |
| Profit before tax | 191,545 | 255,921 | 156,959 | 92,200 | 181,728 | 302,975 | 492,898 | 853,064 |
| Net profit | 186,732 | 252,914 | 156,021 | 90,325 | 179,375 | 299,481 | 489,626 | 720,020 |
| Equity | 609,236 | 837,150 | 943,170 | 845,260 | 774,635 | 1,074,116 | 1,332,742 | 1,254,762 |
| Liabilities | 88,258 | 92,121 | 59,806 | 94,174 | 159,883 | 54,187 | 128,318 | 273,708 |
| Non-current assets | 180,303 | 390,195 | 588,670 | 520,758 | 605,480 | 658,737 | 334,322 | 290,994 |
| Current assets | 517,191 | 539,076 | 409,475 | 411,102 | 323,677 | 466,604 | 1,126,738 | 1,237,476 |
| Total assets | 697,494 | 929,271 | 998,145 | 931,860 | 929,157 | 1,125,341 | 1,461,060 | 1,528,470 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 112,626 | 179,884 | 265,969 |
| Social insurance contributions | - | - | - | - | - | 142,829 | 178,994 | 209,060 |
|
Financial indicators
|
||||||||
| Revenue change y/y | +17.9% | +13.9% | -19.0% | +6.1% | +34.2% | +41.7% | +37.6% | +13.7% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 26.8% | 27.2% | 15.6% | 9.7% | 19.3% | 26.6% | 33.5% | 47.1% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 30.7% | 30.2% | 16.5% | 10.7% | 23.2% | 27.9% | 36.7% | 57.4% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 25.8% | 30.7% | 23.4% | 12.8% | 18.9% | 22.3% | 26.4% | 34.2% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 26.5% | 31.1% | 23.5% | 13.0% | 19.1% | 22.5% | 26.6% | 40.5% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 0.1 | 0.1 | 0.1 | 0.1 | 0.2 | 0.1 | 0.1 | 0.2 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 16,213 | 18,682 | 15,757 | 16,845 | 22,654 | 28,282 | 35,490 | 39,594 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Žemaitijos diagnostikos centras - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2025-03-18 | 2025-03-26 | 179.73 |
| 2022-05-17 | 2022-06-08 | 36.00 |
| 2022-01-28 | 2022-02-13 | 1.68 |
| 2021-12-30 | 2022-01-11 | 0.06 |
| 2021-12-16 | 2021-12-19 | 1133.20 |
Žemaitijos diagnostikos centras - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2026-04-30 | 2026-04-30 | 8.72 |
| 2025-12-18 | 2025-12-29 | 0.23 |
| 2025-12-01 | 2025-12-15 | 0.08 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Žemaitijos diagnostikos centras, UAB (code 302260537) is a Private Limited Liability Company operating in general medical practice activities. In 2025, the company generated revenue of €2.11M, up 13.7% year on year and 56.4% over two years. Net profit reached €720.0K, up from €489.6K in 2024 and €299.5K in 2023, showing a clear upward earnings trajectory. The net profit margin improved to 34.2% in 2025 from 26.4% in 2024 and 22.3% in 2023, indicating stronger profitability. Balance sheet size remained solid, with total assets of €1.53M and equity of €1.25M at the end of 2025. Liabilities increased to €273.7K, while the equity ratio stayed high at 82.1% and debt-to-equity was 0.22. Asset turnover stood at 1.38x, ROE at 57.4% and ROA at 47.1%. Revenue per employee was €39.7K, and profit per employee was €13.6K, supporting the view of a profitable and efficiently operated medical services business.